icd10free.comPowered by Curo

ICD-10 Coding for Cancer Antigen 19-9(C25.9, K86.1, R97.2)

Save

Comprehensive guide on ICD-10 coding for Cancer Antigen 19-9, including primary and ancillary codes, documentation requirements, and common pitfalls.

Also known as:
CA 19-9Carbohydrate Antigen 19-9
Related ICD-10 Code Ranges

Complete code families applicable to Cancer Antigen 19-9

C00-D49Primary Range

Neoplasms

→
Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescription
C25.9Malignant neoplasm of pancreas, unspecified
R97.2Elevated tumor marker
Primary ICD-10-CM Codes
Malignant neoplasm of pancreas, unspecified
C25.9Billable
Differential Codes

Alternative codes to consider when ruling out similar conditions

Chronic pancreatitisK86.1

Use when imaging shows chronic pancreatitis without malignancy.

Malignant neoplasm of pancreasC25.9

Documentation & Coding Risks

Avoid these common issues when documenting Cancer Antigen 19-9.

Failing to document clinical indication for CA 19-9 testing

Impact

Clinical: May lead to inappropriate testing., Regulatory: Non-compliance with documentation standards., Financial: Potential claim denials.

Mitigation

Always include a clinical rationale in the patient's record.

Using R97.2 as a standalone code for cancer monitoring

Impact

Reimbursement: Claims may be denied due to lack of specificity., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate representation of patient condition.

Mitigation

Always pair with a primary malignancy code like C25.9.

Inadequate documentation for CA 19-9 testing

Impact

Lack of detailed clinical context can trigger audits.

Mitigation

Ensure comprehensive documentation of clinical indications and test results.

Frequently Asked Questions

Related condition guides

Documentation requirements, coding pitfalls and FAQs for conditions coded with C25.9.